511
Participants
Start Date
December 10, 2013
Primary Completion Date
November 10, 2015
Study Completion Date
November 21, 2017
Atorvastatin
Atorvastatin was supplied as over-encapsulated 20 mg tablets
Placebo to Atorvastatin
Placebo matching to atorvastatin supplied as over-encapsulated tablets
Placebo to Ezetimibe
Placebo matching to Ezetimibe supplied as over-encapsulated tablets.
Ezetimibe
Ezetimibe was supplied as 10 mg tablets, over-encapsulated for blinding.
Placebo to Evolocumab
Placebo matching to evolocumab supplied as single-use prefilled autoinjector/pen(s)
Evolocumab
Evolocumab supplied as single-use prefilled autoinjector/pen(s)
Research Site, Midrand
Research Site, Camperdown
Research Site, Johannesburg
Research Site, Glostrup Municipality
Research Site, Woolloongabba
Research Site, Ashford
Research Site, Ålesund
Research Site, Parow
Research Site, Observatory
Research Site, Christchurch
Research Site, Aarhus N
Research Site, New York
Research Site, Berlin
Research Site, York
Research Site, Cinisello Balsamo (MI)
Research Site, Baltimore
Research Site, Towson
Research Site, Durham
Research Site, Charleston
Research Site, Atlanta
Research Site, Bologna
Research Site, Nantes
Research Site, Ferrara
Research Site, Cleveland
Research Site, Ann Arbor
Research Site, Cologne
Research Site, Rochester
Research Site, Pisa
Research Site, Sterling
Research Site, St Louis
Research Site, Kansas City
Research Site, Vénissieux
Research Site, Paris
Research Site, Houston
Research Site, München
Research Site, Los Angeles
Research Site, Beverly Hills
Research Site, San Pedro
Research Site, Huntington Beach
Research Site, Vancouver
Research Site, Hamilton
Research Site, London
Research Site, Peterborough
Research Site, Montreal
Research Site, Québec
Research Site, Saint-Charles-Borromée
Research Site, Hradec Králové
Research Site, Prague
Research Site, Prague
Research Site, Cagliari
Research Site, Perugia
Research Site, Amsterdam
Research Site, Rotterdam
Research Site, Zwijndrecht
Research Site, Oslo
Research Site, Birmingham
Research Site, Glasgow
Research Site, Newcastle upon Tyne
Lead Sponsor
Amgen
INDUSTRY